267
Views
11
CrossRef citations to date
0
Altmetric
Articles

Evodiamine activates AMPK and promotes adiponectin multimerization in 3T3-L1 adipocytes

, , , , , , , & show all
Pages 1074-1083 | Received 15 Jan 2014, Accepted 24 Jun 2014, Published online: 01 Aug 2014
 

Abstract

Adiponectin, an adipokine with insulin-sensitizing effect, is secreted from adipocytes into circulation as high, medium, and low molecular weight (HMW, MMW, and LMW) forms. The HMW adiponectin is more metabolically active and the ratio of HMW adiponectin to total adiponectin directly correlates with insulin sensitivity. Evodiamine is an indole alkaloid found in the traditional Chinese medicinal plant Evodia rutaecarpa. In this study, evodiamine was found to activate AMP-activated protein kinase (AMPK) in both 3T3-L1 adipocytes and 293T cells. Activation of AMPK by evodiamine promoted the assembly of HMW adiponectin and increased the HMW/total ratio of adiponectin in 3T3-L1 adipocytes. The Ca2+-dependent PI3K/Akt/CaMKII-signaling pathway was demonstrated to be involved in evodiamine-induced AMPK activation. This study revealed a novel role of this Ca2+-mediated signaling pathway in promoting the multimerization of adiponectin.

Acknowledgments

This work was supported by the National Fund for Talent Training in Basic Science (No. J1030622), the NSFC (Nos 30470354 and 30570356), and the Program for New Century Excellent Talents in University (NCET).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.